Compounds > 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid
Page last updated: 2024-10-21

5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid and Crohn Disease

5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid has been researched along with Crohn Disease in 1 studies

5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid: RN given refers to (S-(R*,R*-(E,E,Z,Z)))-isomer

Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nielsen, OH1
Ahnfelt-Rønne, I1
Elmgreen, J1

Other Studies

1 other study available for 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid and Crohn Disease

ArticleYear
Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils.
    Gut, 1987, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Arachidonic Acid; Arachidonic Acids; Calcimycin; Colitis, Ulcerative; Crohn Disea

1987